NutriSelect Q1 2026 Update - From Foundation to Execution: Building What Comes Next

A Quarter of Acceleration

As we move through the first quarter of 2026, NutriSelect.ai has entered a new phase.

Where last year was about building the foundation, this quarter has been about bringing the platform to life—translating vision into product, partnerships, and real-world execution.

The shift is tangible.

We are no longer preparing to build.
We are building.

Platform Progress: From Concept to Experience

One of the most significant milestones this quarter has been the advancement of the NutriSelect platform itself.

We have:

  • Completed and refined MVP v2, with a fully mapped user journey
  • Developed a live demo experience showcasing the platform in action
  • Advanced core system architecture supporting Precision Supplement Intelligence™ (PSI)
  • Continued development toward v3, focused on scalability and enhanced functionality

This work represents a critical transition—from conceptual design to a functional, testable product experience.

For the first time, what we’ve envisioned can now be seen, experienced, and refined.

Expanding the Scientific & Data Ecosystem

NutriSelect was never designed to operate in isolation.

This quarter, we made meaningful progress in building a collaborative scientific ecosystem that will power the integrity of the platform.

Key developments include:

  • Expansion of our CRO Consortium, supporting clinical validation and data generation
  • Formalization of our first laboratory partnership with Alkemist Labs, strengthening analytical credibility
  • Continued engagement with research organizations and validation partners to support product-level evidence development

These relationships are foundational.

They ensure that NutriSelect is not just interpreting data—but helping shape how future evidence is created, validated, and applied.

Accelerator Programs: Building the Data Layer

We officially advanced our Ingredient Science Accelerator™ and Product Science Accelerator™ programs this quarter.

These programs are designed to:

  • Collaborate with leading ingredient suppliers and brands
  • Build structured scientific datasets that feed the NScore™ system
  • Identify and close evidence gaps through targeted research strategies

We are currently engaged in active discussions with multiple partners across the ecosystem, with early cohorts beginning to take shape.

This is where the platform’s intelligence begins to compound.

Raising with Discipline

Investor engagement has continued to grow in Q1, with ongoing conversations across North America, Europe, and beyond.

Our approach remains unchanged.

We are prioritizing alignment over speed—seeking partners who understand:

  • The complexity of regulated health markets
  • The importance of scientific credibility
  • The long-term value of building an independent intelligence platform

The opportunity is significant, but so is the responsibility.

We are building accordingly.

Industry Context: The Signal Is Getting Louder

The broader market is beginning to reflect the shift we’ve been preparing for.

Across healthcare and wellness, we are seeing:

  • Rapid adoption of AI-driven decision tools
  • Increased demand for evidence-based validation
  • Growing awareness of the limitations of current supplement evaluation models

At the same time, many organizations are experiencing what we call the “junk drawer problem”—a fragmented approach to AI that lacks strategy and cohesion.

NutriSelect is being built differently.

Not as a collection of tools—but as a unified intelligence layer grounded in science.

Looking Ahead

As we move into Q2, our priorities are focused and intentional:

  • Advancing toward a controlled platform release
  • Expanding accelerator cohorts and scientific datasets
  • Continuing development of PSI™ and NScore™ capabilities
  • Strengthening strategic partnerships across the ecosystem

Each step builds toward a singular goal:

Delivering a platform that brings clarity, credibility, and precision to supplement decision-making at scale.

Thank You for Being Part of This

To our growing community of subscribers, partners, advisors, and supporters—thank you.

Your engagement continues to validate the importance of this mission.

We are building something that has the potential to reshape how health decisions are made.

And we’re just getting started.


Founder’s Note

NutriSelect.ai is now entering the phase where ideas are no longer enough.

Execution is everything.

This quarter has been about crossing that threshold—taking what has lived in models, frameworks, and strategy, and turning it into something tangible.

Something real.

What has become increasingly clear is that the problem we are solving is even larger than originally framed.

This is not just about supplements.

It’s about how science is translated into decisions—and whether people can trust the systems guiding those decisions.

AI will play a central role in that future.

But only if it is built on the right foundation.

That is what we are doing with NutriSelect.

Deliberately. Thoughtfully. And with long-term conviction.

Thank you for being part of this journey.

— Dr. Bill Clark, PhD
Founder & CEO, NutriSelect.ai